On Tuesday, Cathie Wood’s Ark Invest made a significant move by increasing its stake in Moderna Inc. (NASDAQ:MRNA), a leading COVID-19 vaccine maker. This move comes amidst a series of upcoming catalysts for the biotech firm. The MRNA Trade Ark Invest, through its flagship Ark Innovation ETF (NYSE:ARKK), purchased a whopping 72,800 shares of Moderna. Based on the closing price of $107.41 on the same day, the value of this trade stands at approximately $7.82 million. This move indicates a strong belief in the biotech firm’s potential, as Ark Invest has been consistently increasing its holdings …